Heng Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Heng Gao has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Cheng Cao
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China; Department of Intensive Care Unit, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin City 214400, Jiangsu Province, China; Department of Brain Center, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin City 214400, Jiangsu Province, China
2 shared publicationsLingjuan Gao
Department of Neurosurgery, Jiangyin Clinical College of Xuzhou Medical University
2 shared publications- Cheng Cao
Department of Brain Center, Jiangyin Clinical College of Xuzhou Medical University
1 shared publication - Gang Cui
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China
1 shared publication Hai Zhao
Department of Emergency Medicine, Jiangyin Clinical College of Xuzhou Medical University
1 shared publication- Haitao Shen
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1852115
Mitochondrial metabolic remodeling and blood–brain barrier dysfunction after repetitive mild traumatic brain injury
Repetitive mild traumatic brain injury (rmTBI) may arise when concussive or subconcussive impacts recur before physiological recovery is complete. Mitochondrial dysfunction and blood–brain barrier (BBB) impairment are shared features across the traumatic brain injury (TBI) spectrum; in rmTBI, repetition may alter their magnitude, duration, and temporal coupling. This focused narrative review evaluates evidence that mitochondrial metabolic remodeling contributes to neurovascular-unit dysfunction after rmTBI. We discuss energy failure, mitochondrial reactive oxygen species, succinate, fumarate, alpha-ketoglutarate, NAD + depletion, and lactate as candidate links between metabolic stress and BBB injury. Direct rmTBI evidence is prioritized, while single-TBI studies are used as mechanistic context when rmTBI data are limited. Available studies support a model in which recurrent metabolic stress, redox imbalance, inflammatory signaling, and impaired mitochondrial quality control converge on endothelial and multicellular neurovascular-unit dysfunction. Metabolism-directed interventions are promising but require validation across rigorously defined rmTBI paradigms and clinical cohorts.
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1852115
Open AccessMitochondrial metabolic remodeling and blood–brain barrier dysfunction after repetitive mild traumatic brain injury
Repetitive mild traumatic brain injury (rmTBI) may arise when concussive or subconcussive impacts recur before physiological recovery is complete. Mitochondrial dysfunction and blood–brain barrier (BBB) impairment are shared features across the traumatic brain injury (TBI) spectrum; in rmTBI, repetition may alter their magnitude, duration, and temporal coupling. This focused narrative review evaluates evidence that mitochondrial metabolic remodeling contributes to neurovascular-unit dysfunction after rmTBI. We discuss energy failure, mitochondrial reactive oxygen species, succinate, fumarate, alpha-ketoglutarate, NAD + depletion, and lactate as candidate links between metabolic stress and BBB injury. Direct rmTBI evidence is prioritized, while single-TBI studies are used as mechanistic context when rmTBI data are limited. Available studies support a model in which recurrent metabolic stress, redox imbalance, inflammatory signaling, and impaired mitochondrial quality control converge on endothelial and multicellular neurovascular-unit dysfunction. Metabolism-directed interventions are promising but require validation across rigorously defined rmTBI paradigms and clinical cohorts.
- Open Access
- 24 June 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1826985
Comparative associations of the TyG index and HOMA2-IR with 6-month outcomes after moderate-to-severe traumatic brain injury: a single-center retrospective cohort study
Background: The triglyceride glucose (TyG) index and the homeostatic model assessment 2 of insulin resistance (HOMA2-IR) are both valid markers for assessing insulin resistance (IR) and may serve as early metabolic biomarkers associated with outcomes in patients with moderate-to-severe traumatic brain injury (msTBI). This study was designed to directly compare the TyG index and HOMA2-IR regarding their associations with 6-month outcomes in msTBI patients. Methods: This study conducted a single-center, retrospective cohort of 362 consecutive patients with msTBI admitted to the Jiangyin Clinical College of Xuzhou Medical University. Six-month outcomes were evaluated using the Glasgow Outcome Scale–Extended (GOSE) and dichotomized as favorable (GOSE ≥ 5) or unfavorable (GOSE ≤ 4). In this study core IMPACT-CT variables were collected (Glasgow Coma Scale score, age, pupillary reactivity, and Marshall CT score), sex, and two IR indices. Analyses included univariable comparisons by the outcome group, evaluation of the correlation between the TyG index and HOMA2-IR, generalized additive models (GAMs) to assess potential non-linearity, and multivariable models with adjusted restricted cubic splines (RCSs) to confirm and characterize non-linear associations of the TyG index and HOMA2-IR with outcome and to clarify their independent contributions. Clinical utility was evaluated using decision curve analysis (DCA) to determine net benefit. Results: All core IMPACT-CT variables and both IR indices differed significantly by the outcome group. The TyG index and HOMA2-IR were moderately correlated. GAMs indicated a mildly non-linear negative association between the TyG index and an approximately linear negative association between HOMA2-IR and the outcome. RCSs confirmed that both indices were strongly associated with outcome and similarly improved discrimination, whereas the TyG index showed greater independent contribution and a broader range of net benefit on DCA. Conclusion: Both the TyG index and HOMA2-IR were significantly associated with unfavorable outcomes and improved the performance of models based on core IMPACT-CT variables in this single-center retrospective cohort study. Although their overall discrimination was similar, the TyG index showed a modest but consistent advantage in independent contribution and net clinical benefit, and it was easier to implement in clinical practice.
- 24 June 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1826985
Open AccessComparative associations of the TyG index and HOMA2-IR with 6-month outcomes after moderate-to-severe traumatic brain injury: a single-center retrospective cohort study
Background: The triglyceride glucose (TyG) index and the homeostatic model assessment 2 of insulin resistance (HOMA2-IR) are both valid markers for assessing insulin resistance (IR) and may serve as early metabolic biomarkers associated with outcomes in patients with moderate-to-severe traumatic brain injury (msTBI). This study was designed to directly compare the TyG index and HOMA2-IR regarding their associations with 6-month outcomes in msTBI patients. Methods: This study conducted a single-center, retrospective cohort of 362 consecutive patients with msTBI admitted to the Jiangyin Clinical College of Xuzhou Medical University. Six-month outcomes were evaluated using the Glasgow Outcome Scale–Extended (GOSE) and dichotomized as favorable (GOSE ≥ 5) or unfavorable (GOSE ≤ 4). In this study core IMPACT-CT variables were collected (Glasgow Coma Scale score, age, pupillary reactivity, and Marshall CT score), sex, and two IR indices. Analyses included univariable comparisons by the outcome group, evaluation of the correlation between the TyG index and HOMA2-IR, generalized additive models (GAMs) to assess potential non-linearity, and multivariable models with adjusted restricted cubic splines (RCSs) to confirm and characterize non-linear associations of the TyG index and HOMA2-IR with outcome and to clarify their independent contributions. Clinical utility was evaluated using decision curve analysis (DCA) to determine net benefit. Results: All core IMPACT-CT variables and both IR indices differed significantly by the outcome group. The TyG index and HOMA2-IR were moderately correlated. GAMs indicated a mildly non-linear negative association between the TyG index and an approximately linear negative association between HOMA2-IR and the outcome. RCSs confirmed that both indices were strongly associated with outcome and similarly improved discrimination, whereas the TyG index showed greater independent contribution and a broader range of net benefit on DCA. Conclusion: Both the TyG index and HOMA2-IR were significantly associated with unfavorable outcomes and improved the performance of models based on core IMPACT-CT variables in this single-center retrospective cohort study. Although their overall discrimination was similar, the TyG index showed a modest but consistent advantage in independent contribution and net clinical benefit, and it was easier to implement in clinical practice.
- 28 August 2023
- Published by Elsevier in Brain Research
- Vol. 1820, 148556
Restoring System xc- activity by xCT overexpression inhibited neuronal ferroptosis and improved neurological deficits after experimental subarachnoid hemorrhage
- 28 August 2023
- Published by Elsevier in Brain Research
- Vol. 1820, 148556
Restoring System xc- activity by xCT overexpression inhibited neuronal ferroptosis and improved neurological deficits after experimental subarachnoid hemorrhage
- Open Access
- 28 July 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 949091
Insulin resistance is associated with an unfavorable outcome among non-diabetic patients with isolated moderate-to-severe traumatic brain injury – A propensity score-matched study
Background: Hyperglycemia is an independent risk factor for the poor prognosis in patients with traumatic brain injury (TBI), and stress-induced impaired insulin function is the major factor of hyperglycemia in non-diabetic patients with TBI. Several types of research suggested that insulin resistance (IR) is related to the poor prognosis of neurocritical ill patients; here we focused on the role of IR in non-diabetic patients after TBI.Methods: We performed a prospective observational study with the approval of the Ethics Committee of our institute. IR was accessed via the update Homeostasis Model Assessment (HOMA2) of IR, a computer-calculated index by glucose and insulin level. HOMA2 ≥ 1.4 was considered as the threshold of IR according to the previous studies. The glycemic variability (GV) indices were calculated by fingertip blood glucose concentration at an interval of 2 h within 24 h to explore the relationship between IR and GV. The outcome was the 6-month neurological outcome evaluated with the Glasgow outcome scale.Results: A total of 85 patients with isolated moderate-to-severe TBI (admission GCS ≤ 12) were finally included in our study, 34 (40%) were diagnosed with IR with HOMA2 ≥ 1.4. After propensity score matching (PSM), 22 patients in IR group were matched to 34 patients in non-IR group. Patients with IR suffered increased systemic glycemic variation after isolated moderate-to-severe TBI. IR was a significant factor for the poor prognosis after TBI (OR = 3.25, 95% CI 1.03–10.31, p = 0.041).Conclusions: The IR estimated by HOMA2 was associated with greater GV and an unfavorable outcome after isolated moderate-to-severe TBI. Ameliorating impaired insulin sensitivity may be a potential therapeutic strategy for the management of TBI patients.
- 28 July 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 949091
Open AccessInsulin resistance is associated with an unfavorable outcome among non-diabetic patients with isolated moderate-to-severe traumatic brain injury – A propensity score-matched study
Background: Hyperglycemia is an independent risk factor for the poor prognosis in patients with traumatic brain injury (TBI), and stress-induced impaired insulin function is the major factor of hyperglycemia in non-diabetic patients with TBI. Several types of research suggested that insulin resistance (IR) is related to the poor prognosis of neurocritical ill patients; here we focused on the role of IR in non-diabetic patients after TBI.Methods: We performed a prospective observational study with the approval of the Ethics Committee of our institute. IR was accessed via the update Homeostasis Model Assessment (HOMA2) of IR, a computer-calculated index by glucose and insulin level. HOMA2 ≥ 1.4 was considered as the threshold of IR according to the previous studies. The glycemic variability (GV) indices were calculated by fingertip blood glucose concentration at an interval of 2 h within 24 h to explore the relationship between IR and GV. The outcome was the 6-month neurological outcome evaluated with the Glasgow outcome scale.Results: A total of 85 patients with isolated moderate-to-severe TBI (admission GCS ≤ 12) were finally included in our study, 34 (40%) were diagnosed with IR with HOMA2 ≥ 1.4. After propensity score matching (PSM), 22 patients in IR group were matched to 34 patients in non-IR group. Patients with IR suffered increased systemic glycemic variation after isolated moderate-to-severe TBI. IR was a significant factor for the poor prognosis after TBI (OR = 3.25, 95% CI 1.03–10.31, p = 0.041).Conclusions: The IR estimated by HOMA2 was associated with greater GV and an unfavorable outcome after isolated moderate-to-severe TBI. Ameliorating impaired insulin sensitivity may be a potential therapeutic strategy for the management of TBI patients.